Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Completed · Phase 1/Phase 2

Conditions studied: Immune Thrombocytopenic Purpura

In brief

The purpose of this study is to assess the safety and tolerability of BMS-986004 when administered in subjects with ITP.

Key facts

Study ID: NCT02273960
Run by: Bristol-Myers Squibb
People needed: 46
Starts: 2014-11-17
Expected to finish: 2018-01-22
Last updated by the study team: 2019-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

≥18 years old, diagnosed with persistent or chronic ITP

You may not qualify if…

Secondary immune thrombocytopenia
Drug induced thrombocytopenia

Where it is running

Univ. Of Southern Calif. /Norris Comprehensive Cancer Center — Los Angeles, California, United States
Georgetown University Medical Center — Washington D.C., District of Columbia, United States
Emory University — Atlanta, Georgia, United States
Columbus Regional Research Institute — Columbus, Georgia, United States
Mass General Hospital — Boston, Massachusetts, United States
Rutgers- Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
Local Institution — Randwick, New South Wales, Australia
Local Institution — Brisbane, Queensland, Australia
Hamilton Health Sciences/Mc Master Univ Med Ctre — Hamilton, Ontario, Canada
Local Institution — Tbilisi, Georgia
Local Institution — Chisinau, Moldova
Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych — Chorzów, Poland
Specjalistyczny Gabinet Lekarski Prof. dr hab. Krzysztof Giannopoulos — Lublin, Poland
Local Institution — Warsaw, Poland
Local Institution — Saint Petersburg, Russia
Local Institution — Smolensk, Russia
Local Institution — London, Greater London, United Kingdom
Local Institution — Manchester, Greater Manchester, United Kingdom
Local Institution — Glasgow, Lanarkshire, United Kingdom
Local Institution — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.